Many infants and children tend to outgrow urticaria pigmentosa over time. No treatment is currently known to prevent their ...

The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...

Xolair is used to treat chronic spontaneous urticaria (CSU) in adults and children ages 12 years and ... At week 8 of Xolair treatment, almost half of the people who received Xolair had UAS7 ...

Dr Adam Friedman recounts how AAD 2025 highlighted advancements in chronic spontaneous urticaria management, with discussion ...

Remibrutinib results in significant improvement in composite measure of itching and hives after second-generation H1-antihistamine treatment.

Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch ...

For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H 1-antihistamines, administration of the oral, highly selective Bruton's tyrosine kinase ...